The following is a summary of “Left ventricular systolic function after percutaneous coronary intervention: patterns of ...

Korea: The FLASH Trial has revealed that artificial intelligence-based fully automated quantitative coronary angiography ...

A local hospital has again earned an accreditation for a crucial nonsurgical heart procedure. Chan Soon-Shiong Medical Center ...

Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few ...

African American patients that receive PCI for LMCA disease have increased risk for postdischarge bleeding compared with White patients.

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) ...

The following is a summary of “Early and Long-term Outcomes of Patients with Acute Coronary Syndrome Undergoing Percutaneous ...

Blood thinners are essential medications for many people who have undergone a procedure called percutaneous coronary ...

Inclacumab is a monoclonal antibody commercialized by Pfizer, with a leading Phase III program in Sickle Cell Disease With Vaso-Occlusive Crisis.

CureGene Pharmaceutical ('CureGene'), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...

Tom Nolan reviews this week’s research Established surgical treatment for people with severe aortic stenosis who have obstructive coronary artery disease is surgical aortic valve replacement (SAVR) ...

The companies plan to integrate and pilot their combined technologies to gain insight into improving cardiovascular care.